Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Aalborg – page 15

330 clinical trials in Aalborg, Denmark across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Aalborg at a glance
330
clinical trials
  • Research sites4
Type of trial
Recruitment status
Quick filters

330 trials in Aalborg

Open in trial search

Antiphospholipid antibodies

Not yet recruiting

Study on Hydroxychloroquine for Improving Pregnancy Outcomes in Women with Antiphospholipid Antibodies

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Hydroxychloroquine Sulfate
  • Sponsor:Rigshospitalet

Study Comparing R-MINI-CHOP and R-MINI-CHP with Polatuzumab Vedotin for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older or Frail Patients Aged 75 and Older

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Region Skane

Sarcoidosis

Not yet recruiting

Study on the Effects of XTMAB-16 and Prednisolone in Patients with Pulmonary Sarcoidosis with or without Other Body Involvement

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Prednisolone
  • Sponsor:Xentria Inc.

Psoriasis

Not recruiting

Study on the Effectiveness and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab for Patients with Moderate to Severe Plaque Psoriasis

Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:JNJ-77242113
  • Sponsor:Janssen Cilag International

Study on the Effects of AGA2118 for Postmenopausal Women with Osteoporosis

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:AGA2118
  • Sponsor:Angitia Inc. Ltd.

Study on the Effects of VHB937 in Patients with Amyotrophic Lateral Sclerosis (ALS)

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:VHB937
  • Sponsor:Novartis Pharma AG

Hot flush

Not recruiting

Study of Fezolinetant for Hot Flashes in Women with Hormone Receptor-Positive Breast Cancer Receiving Hormone Therapy

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Fezolinetant
  • Sponsor:Astellas Pharma Global Development Inc.

Ovarian cancer

Not recruiting

Study on the Effectiveness of Durvalumab, Olaparib, and Bevacizumab in Patients with Newly Diagnosed Advanced Ovarian Cancer

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:AstraZeneca AB

Gastric cancer+1

Not recruiting

Study on Durvalumab and FLOT Chemotherapy for Patients with Resectable Gastric and Gastroesophageal Cancer

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:AstraZeneca AB

Study on the Effects of Zibotentan and Dapagliflozin in Patients with Chronic Kidney Disease and High Protein Levels

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:AstraZeneca AB

Study on the Effects of Astegolimab and Drug Combination for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Genentech Inc.

Dyslipidaemia

Not recruiting

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Aalborg

What the registry says about research in the country

01 Oncology Studies

Innovative research focusing on endometrial cancer and metastatic prostate cancer treatments. Studies evaluating new therapeutic combinations and investigating cannabidiol's potential in cancer care.

  • Advanced breast cancer therapy evaluation
  • Cancer-related fatigue management
  • Novel drug combinations assessment

Multiple trials exploring targeted therapies and quality of life improvements for cancer patients.

02 Immunology & Infectious Diseases

Comprehensive studies on meningococcal vaccines and chickenpox prevention in children. Research includes RSV prevention and inflammatory conditions.

  • Vaccine immunogenicity studies
  • Chronic rhinosinusitis treatments
  • Plaque psoriasis therapies

Focus on preventive medicine and immune system responses in various age groups.

03 Gastrointestinal & Metabolic Disorders

Investigations into inflammatory bowel diseases including studies on Crohn's Disease and Ulcerative Colitis. Research on opioid-induced bowel dysfunction.

  • Therapeutic drug monitoring
  • Bowel dysfunction treatments
  • Novel therapeutic combinations

Advancing understanding of digestive system disorders and their management.

04 Cardiovascular & Renal Studies

Research on chronic kidney disease treatments and heart failure prevention. Studies examining new approaches for cardiovascular disease management.

  • Heart failure prevention strategies
  • Kidney disease therapies
  • Cardiovascular risk reduction

Innovative approaches to managing complex cardio-renal conditions.

05 Neurological & Psychiatric Research

Studies investigating treatments for amyotrophic lateral sclerosis and dual diagnosis of schizophrenia with alcohol use disorder.

  • ALS treatment development
  • Psychiatric disorder management
  • Neurological disease therapies

Exploring new therapeutic options for complex neurological and psychiatric conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.